Executive functioning in schizophrenia spectrum disorder patients and their unaffected siblings: A ten-year follow-up study

Schizophrenia Research

Volumn 143, Issue 2-3, 2013, Pages 291-296

  Sánchez Torres, Ana M ^a   Basterra, Virginia ^a   Moreno Izco, Lucía ^a   Rosa, Araceli ^a   Fañanás, Lourdes ^a   Zarzuela, Amalia ^a   Peralta, Victor ^a   Cuesta, Manuel J ^a  

^a Universidad Pública de Navarra   (Spain)

Author keywords

Executive function; Longitudinal study; Psychosis; Schizophrenia spectrum disorders; Siblings

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; COGNITIVE DEFECT; CONTROLLED STUDY; EXECUTIVE FUNCTION; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SIBLING; SUBSTANCE ABUSE; TRAIL MAKING TEST B; WISCONSIN CARD SORTING TEST;

ADULT; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SIBLINGS; TIME FACTORS; YOUNG ADULT;

EID: 84872393737     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.11.026     Document Type: Article

References (50)

1. Altshuler L., Tekell J., Biswas K., Kilbourne A.M., Evans D., Tang D., Bauer M.S. Executive function and employment status among veterans with bipolar disorder. Psychiatr. Serv. 2007, 58(11):1441-1447.
2. Andreasen N.C., Flaum M., Arndt S. The Comprehensive Assessment of Symptoms and History (CASH), an instrument for assessing diagnosis and psychopathology. Arch. Gen. Psychiatry 1992, 49(8):615-623.
3. APA Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 1994, American Psychiatric Association, Washington.
4. Bartels C., Wegrzyn M., Wiedl A., Ackermann V., Ehrenreich H. Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing. BMC Neurosci. 2010, 11:118.
5. Basso M.R., Bornstein R.A., Lang J.M. Practice effects on commonly used measures of executive function across twelve months. Clin. Neuropsychol. 1999, 13(3):283-292.
6. Beglinger L.J., Gaydos B., Tangphao-Daniels O., Duff K., Kareken D.A., Crawford J., Fastenau P.S., Siemers E.R. Practice effects and the use of alternate forms in serial neuropsychological testing. Arch. Clin. Neuropsychol. 2005, 20(4):517-529.
7. Bowie C.R., Leung W.W., Reichenberg A., McClure M.M., Patterson T.L., Heaton R.K., Harvey P.D. Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biol. Psychiatry 2008, 63(5):505-511.
8. Cannon T.D., Bearden C.E., Hollister J.M., Rosso I.M., Sanchez L.E., Hadley T. Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr. Bull. 2000, 26(2):379-393.
9. Cannon M., Moffitt T.E., Caspi A., Murray R.M., Harrington H., Poulton R. Neuropsychological performance at the age of 13years and adult schizophreniform disorder: prospective birth cohort study. Br. J. Psychiatry 2006, 189:463-464.
10. Censits D.M., Ragland J.D., Gur R.C., Gur R.E. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr. Res. 1997, 24(3):289-298.
11. Chan R.C., Chen E.Y., Cheung E.F., Chen R.Y., Cheung H.K. The components of executive functioning in a cohort of patients with chronic schizophrenia: a multiple single-case study design. Schizophr. Res. 2006, 81(2-3):173-189.
12. Chan R.C., Chen E.Y., Law C.W. Specific executive dysfunction in patients with first-episode medication-nayive schizophrenia. Schizophr. Res. 2006, 82(1):51-64.
13. Cuesta M.J., Peralta V., Zarzuela A. Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophr. Res. 2001, 48(1):17-28.
14. Cuesta M.J., García de Jalon E., Campos M.S., Peralta V. Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis. Br. J. Psychiatry 2009, 194(5):439-445.
15. Evans C., Margison F., Barkham M. The contribution of reliable and clinically significant change methods to evidence-based mental health. Evid. Based Ment. Health 1998, 1:70-72.
16. Fett A.K., Viechtbauer W., Dominguez M.D., Penn D.L., van Os J., Krabbendam L. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci. Biobehav. Rev. 2011, 35(3):573-588.
17. Fucetola R., Seidman L.J., Kremen W.S., Faraone S.V., Goldstein J.M., Tsuang M.T. Age and neuropsychologic function in schizophrenia: a decline in executive abilities beyond that observed in healthy volunteers. Biol. Psychiatry 2000, 48(2):137-146.
18. Gold S., Arndt S., Nopoulos P., O'Leary D.S., Andreasen N.C. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am. J. Psychiatry 1999, 156(9):1342-1348.
19. Gold J.M., Hahn B., Strauss G.P., Waltz J.A. Turning it upside down: areas of preserved cognitive function in schizophrenia. Neuropsychol. Rev. 2009, 19(3):294-311.
20. Goldberg T.E., David A., Gold J.M. Neurocognitive deficits in schizophrenia. Schizophrenia 2003, 168-184. Blackwell Science, Oxford. 2nd ed. S.R. Hirsch, D. Weinberger (Eds.).
21. Goldberg T.E., Keefe R.S., Goldman R.S., Robinson D.G., Harvey P.D. Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies. Neuropsychopharmacology 2010, 35(5):1053-1062.
22. Greenwood K.E., Morris R., Sigmundsson T., Landau S., Wykes T. Executive functioning in schizophrenia and the relationship with symptom profile and chronicity. J. Int. Neuropsychol. Soc. 2008, 14(5):782-792.
23. Harvey P.D., Wingo A.P., Burdick K.E., Baldessarini R.J. Cognition and disability in bipolar disorder: lessons from schizophrenia research. Bipolar Disord. 2010, 12(4):364-375.
24. Heaton R.K., Chelune G.J., Talley J.L., Talley J.L., Kay G.G., Curtiss G. Wisconsin Card Sorting Test (WCST)-CV-64 Psychological Assessment Resources 1993, Odessa, FL.
25. Heaton R.K., Gladsjo J.A., Palmer B.W., Kuck J., Marcotte T.D., Jeste D.V. Stability and course of neuropsychological deficits in schizophrenia. Arch. Gen. Psychiatry 2001, 58(1):24-32.
26. Hoff A.L., Riordan H., O'Donnell D.W., Morris L., DeLisi L.E. Neuropsychological functioning of first-episode schizophreniform patients. Am. J. Psychiatry 1992, 149(7):898-903.
27. Hoff A.L., Svetina C., Shields G., Stewart J., DeLisi L.E. Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia. Schizophr. Res. 2005, 78(1):27-34.
28. Hughes C., Kumari V., Das M., Zachariah E., Ettinger U., Sumich A., Sharma T. Cognitive functioning in siblings discordant for schizophrenia. Acta Psychiatr. Scand. 2005, 111(3):185-192.
29. Jacobson N.S., Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J. Consult. Clin. Psychol. 1991, 59(1):12-19.
30. Johnson-Selfridge M., Zalewski C. Moderator variables of executive functioning in schizophrenia: meta-analytic findings. Schizophr. Bull. 2001, 27(2):305-316.
31. Liu K.C.M., Chan R.C.K., Chan K.K.S., Tang J.Y.M., Chiu C.P.Y., Lam M.M.L., Chan S.K.W., Wong G.H.Y., Hui C.L.M., Chen E.Y.H. Executive function in first-episode schizophrenia: a three-year longitudinal study of an ecologically valid test. Schizophr. Res. 2011, 126(1-3):87-92.
32. Meltzer H.Y., McGurk S.R. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr. Bull. 1999, 25(2):233-255.
33. Miyake A., Friedman N.P., Emerson M.J., Witzki A.H., Howerter A., Wager T.D. The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis. Cogn. Psychol. 2000, 41(1):49-100.
34. Mur M., Portella M.J., Martinez-Aran A., Pifarre J., Vieta E. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients. J. Clin. Psychiatry 2008, 69(5):712-719.
35. Reeder C., Newton E., Frangou S., Wykes T. Which executive skills should we target to affect social functioning and symptom change? A study of a cognitive remediation therapy program. Schizophr. Bull. 2004, 30(1):87-100.
36. Reitan R., Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation 1993, Neuropsychology Press, Tucson, AZ.
37. Rosa A., Peralta V., Papiol S., Cuesta M.J., Serrano F., Martinez-Larrea A., Fananas L. Interleukin-1beta (IL-1beta) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004, 124B(1):10-14.
38. Rund B.R. A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophr. Bull. 1998, 24(3):425-435.
39. Schulze K.K., Walshe M., Stahl D., Hall M.H., Kravariti E., Morris R., Marshall N., McDonald C., Murray R.M., Bramon E. Executive functioning in familial bipolar I disorder patients and their unaffected relatives. Bipolar Disord. 2011, 13(2):208-216.
40. Semkovska M., Bedard M.A., Godbout L., Limoge F., Stip E. Assessment of executive dysfunction during activities of daily living in schizophrenia. Schizophr. Res. 2004, 69(2-3):289-300.
41. Stirling J., White C., Lewis S., Hopkins R., Tantam D., Huddy A., Montague L. Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort. Schizophr. Res. 2003, 65(2-3):75-86.
42. Strauss E., Sherman E.M.S., Spreen O. A Compendium of Neuropsychological Tests 2006, Oxford University Press, New York. 3rd ed.
43. Sweeney J.A., Haas G.L., Keilp J.G., Long M. Evaluation of the stability of neuropsychological functioning after acute episodes of schizophrenia: one-year followup study. Psychiatry Res. 1991, 38(1):63-76.
44. Szoke A., Trandafir A., Dupont M.E., Meary A., Schurhoff F., Leboyer M. Longitudinal studies of cognition in schizophrenia: meta-analysis. Br. J. Psychiatry 2008, 192(4):248-257.
45. Townsend L.A., Norman R.M. Course of cognitive functioning in first episode schizophrenia spectrum disorders. Expert. Rev. Neurother. 2004, 4(1):61-68.
46. Townsend L.A., Norman R.M., Malla A.K., Rychlo A.D., Ahmed R.R. Changes in cognitive functioning following comprehensive treatment for first episode patients with schizophrenia spectrum disorders. Psychiatry Res. 2002, 113(1-2):69-81.
47. World Health Organisation (WHO) Composite International Diagnostic Interview, Version 1.1 1993, WHO, Geneva.
48. Wozniak J.R., Block E.E., White T., Jensen J.B., Schulz S.C. Clinical and neurocognitive course in early-onset psychosis: a longitudinal study of adolescents with schizophrenia-spectrum disorders. Early Interv. Psychiatry 2008, 2(3):169-177.
49. Wykes T., Reeder C., Corner J., Williams C., Everitt B. The effects of neurocognitive remediation on executive processing in patients with schizophrenia. Schizophr. Bull. 1999, 25(2):291-307.
50. Wykes T., Reeder C., Landau S., Everitt B., Knapp M., Patel A., Romeo R. Cognitive remediation therapy in schizophrenia: randomised controlled trial. Br. J. Psychiatry 2007, 190:421-427.